3-(2-fluorophenyl)-7-(furan-3-yl)-2-((2-methyl-2H-1,2,4-triazol-3-yl)methoxy)pyrazolo[1,5-d][1,2,4]triazine

ID: ALA208940

PubChem CID: 9908469

Max Phase: Preclinical

Molecular Formula: C19H14FN7O2

Molecular Weight: 391.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncnc1COc1nn2c(-c3ccoc3)nncc2c1-c1ccccc1F

Standard InChI:  InChI=1S/C19H14FN7O2/c1-26-16(21-11-23-26)10-29-19-17(13-4-2-3-5-14(13)20)15-8-22-24-18(27(15)25-19)12-6-7-28-9-12/h2-9,11H,10H2,1H3

Standard InChI Key:  LYZCPNJIFQNJQM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -4.0311  -16.6532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8475  -16.7972    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9647  -17.6139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2241  -17.9776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6495  -17.3857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8332  -17.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3246  -12.3796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8934  -13.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8966  -12.3756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6148  -11.9669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6128  -13.6202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3272  -13.2040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9437  -13.7548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6103  -14.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7879  -14.4281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0256  -15.2243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6596  -13.3454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6569  -12.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3718  -12.1130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0859  -12.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0806  -13.3571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3651  -13.7635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6158  -15.9404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3575  -14.5885    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1788  -13.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1512  -14.4395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3588  -14.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1046  -13.9867    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4014  -13.3351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  2  3  1  0
 14 16  1  0
 11  8  1  0
 13 17  1  0
  3  4  2  0
 17 18  2  0
  8  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
 10  7  2  0
 21 22  2  0
 22 17  1  0
 11 12  1  0
 16 23  1  0
 23  1  1  0
  5  1  1  0
 22 24  1  0
  8 25  1  0
 25 26  1  0
  5  6  1  0
  1  2  2  0
  7 12  1  0
 12 13  2  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 25  2  0
M  END

Associated Targets(Human)

GABRG2 Tclin GABA-A receptor; alpha-3/beta-3/gamma-2 (1250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA-A receptor; alpha-1/beta-3/gamma-2 (1565 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.37Molecular Weight (Monoisotopic): 391.1193AlogP: 2.90#Rotatable Bonds: 5
Polar Surface Area: 96.16Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.08CX LogP: 2.26CX LogD: 2.26
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: -1.45

References

1. Carling RW, Russell MG, Moore KW, Mitchinson A, Guiblin A, Smith A, Wafford KA, Marshall G, Atack JR, Street LJ..  (2006)  2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.,  16  (13): [PMID:16621541] [10.1016/j.bmcl.2006.03.081]

Source